this post was submitted on 17 Jul 2023
146 points (99.3% liked)

Technology

73698 readers
3379 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related news or articles.
  3. Be excellent to each other!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, this includes using AI responses and summaries. To ask if your bot can be added please contact a mod.
  9. Check for duplicates before posting, duplicates may be removed
  10. Accounts 7 days and younger will have their posts automatically removed.

Approved Bots


founded 2 years ago
MODERATORS
 

Dementia experts hail "watershed moment" after trial results for donanemab antibody treatment.

top 9 comments
sorted by: hot top controversial new old
[–] Mic_Check_One_Two@reddthat.com 17 points 2 years ago

It cleared amyloid plaques completely from the brain in some participants, who were then taken off the drug.

If true, this is genuinely exciting news. It’s not a complete “you’re cured” solution, but it’s better than anything in the past has been able to accomplish. It’d be more akin to cancer remission, where patients will need to be screened every few months to ensure more plaque isn’t starting. But in the interim, they don’t need to continue actively receiving treatments. Just like how cancer survivors go back for scans even after getting the all-clear, because the chances of the cancer returning some time in the future are extremely high.

[–] TheLeechiestLeech@lemmy.dbzer0.com 14 points 2 years ago (2 children)
[–] juliorapido@discuss.tchncs.de 3 points 2 years ago

Wow! This is big. Haven’t heard about this before.

[–] Regna@lemmy.world 2 points 2 years ago

This was a really interesting read.

[–] partial_accumen@lemmy.world 11 points 2 years ago (1 children)

It cleared amyloid plaques completely from the brain in some participants, who were then taken off the drug.

What was the result to the patient outcomes? Did the patients return to pre-demenia state or did their demenia progress simply halt when all the amyloid is cleared (from those patients that got completely cleared of amyloid)?

[–] Regna@lemmy.world 1 points 2 years ago

Sorry, I pressed reply in Voyager, but it ended up as a comment to my post instead of a reply to your comment.

[–] dedale@kbin.social 11 points 2 years ago* (last edited 2 years ago)

Very skeptical of that one.
They've been trying to target amyloid for more than a decade, and it's the first time I hear of it actually working.

The treatment seem to have huge side effects (brain bleeding and swelling) and lead to patient death during the study.
Elly Lilly is also know for marketing zyprexa as a treatment for dementia (despite inefficacy and increased risk of death). Which is IMO criminal, at best unethical. I'm not inclined to trust them at all.

I hope I'm wrong and it works. Alzheimer is a terrible way to go.

[–] Regna@lemmy.world 2 points 2 years ago (1 children)

Considering that it is stated that it helped in earlier stages (before they took the patients off donanemab), I don’t think they got as far as claiming it halted the progress. From the article I mainly had the impression that it slowed it enough in some patients to show some progress in the research. Still, this is hopeful, considering the other options that have been available thus far.

[–] partial_accumen@lemmy.world 3 points 2 years ago

That was my conclusion from the article too, but where I'm interested in is if the amyloid build up causes permanent damage to the brain, causing dementia, or with the removal of amyloid (which was never possible before) does the patient gain back anything they lost?

It seems surprising they left that answer out as it is very compelling to how the disease actually works.

load more comments
view more: next ›